PDF herunterladen
CC BY-NC-ND 4.0 · Ibnosina Journal of Medicine and Biomedical Sciences 2019; 11(04): 171-175
DOI: 10.4103/ijmbs.ijmbs_37_19
Original Article

Prevalence, pattern, and attitudes of smoking among libyan diabetic males: A clinic-based study

Hawa El-Shareif
1   Department of Endocrine, Tripoli Medical Centre, Faculty of Medicine, Tripoli University for Medical Sciences, Tripoli, Libya
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

Introduction: Smoking is a major avoidable cardiovascular risk factor and is a cause of premature death worldwide. Objectives: To study the prevalence, pattern, and awareness of health hazards of smoking among Libyan diabetic male patients in Tripoli Medical Center, Tripoli, Libya. Patients and Methods: A cross-sectional, clinic-based study using a predesigned questionnaire, the participants were interviewed by the author. The interview covered personal data, and questions about their smoking status, and their awareness of smoking hazards. Results: The overall prevalence of current smoking was 26.4% and past smoking 40.3%. The mean age was 50.8 ± 14.4 years (range 18–75 years). The mean age at which smoking started was 18.6 ± 5.3 years; all current smokers were cigarette smokers. Main reason for quitting smoking was related to health issues while social and religious considerations were the main reasons for never smoking. Conclusions: The prevalence of smoking among Libyan diabetic patients was high; this calls for incorporating smoking cessation services within the diabetes care clinics.

Key-words:

Cessation - diabetes - initiation - Libya - smoking

Financial support and sponsorship

Nil.




Publikationsverlauf

Eingereicht: 09. Juli 2019

Angenommen: 22. Oktober 2019

Artikel online veröffentlicht:
07. Juli 2022

© 2019. The Libyan Authority of Scientific Research and Technologyand the Libyan Biotechnology Research Center. All rights reserved. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License,permitting copying and reproductionso long as the original work is given appropriate credit. Contents may not be used for commercial purposes, oradapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 International Diabetes Federation. IDF Diabetes Atlas. 6th ed. Brussels, Belgium, Europe. Brussels: International Diabetes Federation; 2013.
  • 2 American Diabetes Association. American Diabetes Association standards of medical care in diabetes – 2018. Diabetes Care 2018;41 Suppl 1:S1-59.
  • 3 Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, et al. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med 2013;368:341-50.
  • 4 Carter BD, Abnet CC, Feskanich D, Freedman ND, Hartge P, Lewis CE, et al. Smoking and mortality – Beyond established causes. N Engl J Med 2015;372:631-40.
  • 5 Pinto-Sietsma SJ, Mulder J, Janssen WM, Hillege HL, de Zeeuw D, de Jong PE. Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Intern Med 2000;133:585-91.
  • 6 Folsom AR, Szklo M, Stevens J, Liao F, Smith R, Eckfeldt JH, et al. Aprospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes. The atherosclerosis risk in communities (ARIC) study. Diabetes Care 1997;20:935-42.
  • 7 Yacoub R, Habib H, Lahdo A, Al Ali R, Varjabedian L, Atalla G, et al. Association between smoking and chronic kidney disease: A case control study. BMC Public Health 2010;10:731.
  • 8 Abduelkarem AR, El-Shareif HJ, Sharif SI. Evaluation of risk factors in acute myocardial infarction patients admitted to the coronary care unit, Tripoli medical centre, Libya. East Mediterr Health J 2012;18:332-6.
  • 9 Goleg FA, Kong NC, Sahathevan R. Dialysis-treated end-stage kidney disease in Libya: Epidemiology and risk factors. Int Urol Nephrol 2014;46:1581-7.
  • 10 Buargub MA. 5-year mortality in hemodialysis patients: A single center study in Tripoli. Saudi J Kidney Dis Transpl 2008;19:268-73.
  • 11 National Institute for Health and Care Excellence. Type 2 Diabetes in Adults: Management (NICE Guideline 28). National Institute for Health and Care Excellence; 2017. Available from: http: www.nice.org.uk/guidance/ng28. [Last accessed on 2019 May 14].
  • 12 Chaturvedi N, Stevens L, Fuller JH. Which features of smoking determine mortality risk in former cigarette smokers with diabetes? The World Health Organization multinational study group. Diabetes Care 1997;20:1266-72.
  • 13 Roaeid RB, Kablan AA. Profile of diabetes health care at Benghazi diabetes centre, Libyan Arab Jamahiriya. East Mediterr Health J 2007;13:168-76.
  • 14 Beshyah SA. Non-communicable diseases and diabetes care guidelines: Epidemiology and call for collective action. February, 6th 2010, Dat Elmad conference hall complex, Tripoli, Libya. Ibnosina J Med Biomed Sci 2010;2:142-8.
  • 15 Marinho V, Laks J, Coutinho ES, Blay SL. Tobacco use among the elderly: A systematic review and meta-analysis. Cad Saude Publica 2010;26:2213-33.
  • 16 Kukkamalla MA, Pentapati KC, Suresh G, Goyal R, Cornelio SM. Smoking re-initiation after cessation program: Comparison of associated factors between young and older adults. J Nat Sci Biol Med 2013;4:440-4.
  • 17 Chassin L, Presson CC, Sherman SJ, Montello D, McGrew J. Changes in peer and parent influence during adolescence: Longitudinal versus cross-section perspectives on smoking initiation. Dev Psychol 1986;22:327-34.
  • 18 Khabour OF, Alzoubi KH, Eissenberg T, Mehrotra P, Azab M, Carroll MV, et al. Waterpipe tobacco and cigarette smoking among university students in Jordan. Int J Tuberc Lung Dis 2012;16:986-92.
  • 19 Haire-Joshu D, Glasgow RE, Tibbs TL. Smoking and diabetes. Diabetes Care 1999;22:1887-98.
  • 20 US Department of Health and Human Services. The Health Benefits of Smoking Cessation: A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1990.
  • 21 Derman U, Demir G, Akan P. Is awareness of its risk enough to stop people from smoking? J Cancer Educ 1995;10:68-70.
  • 22 Merchant AT, Luby SP, Perveen G. Smoking among males in a low socioeconomic area of Karachi. J Pak Med Assoc 1998;48:62-3.
  • 23 Sieminska A, Buczkowski K, Jassem E, Lewandowska K, Ucinska R, Chelminska M. Patterns of motivations and ways of quitting smoking among polish smokers: A questionnaire study. BMC Public Health 2008;8:274.
  • 24 Hu Y, Zong G, Liu G, Wang M, Rosner B, Pan A, et al. Smoking cessation, weight change, type 2 diabetes, and mortality. N Engl J Med 2018;379:623-32.
  • 25 Lycett D, Nichols L, Ryan R, Farley A, Roalfe A, Mohammed MA, et al. The association between smoking cessation and glycaemic control in patients with type 2 diabetes: A THIN database cohort study. Lancet Diabetes Endocrinol 2015;3:423-30.
  • 26 Zhu S, Melcer T, Sun J, Rosbrook B, Pierce JP. Smoking cessation with and without assistance: A population-based analysis. Am J Prev Med 2000;18:305-11.
  • 27 Chaloupka FJ, Yurekli A, Fong GT. Tobacco taxes as a tobacco control strategy. Tob Control 2012;21:172-80.